Results 1 to 10 of about 45,721 (281)

Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee

Drugs, 2019
Triamcinolone acetonide extended-release (ER) 32 mg (Zilretta®) is approved in the USA for the management of osteoarthritis (OA) pain of the knee and is administered as a single, 5 mL intra-articular (IA) injection.
J. Paik, S. Duggan, S. Keam
semanticscholar   +3 more sources

Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain [PDF]

Journal of Bone and Joint Surgery. American volume, 2018
Background: Intra-articular corticosteroids relieve osteoarthritis pain, but rapid systemic absorption limits efficacy. FX006, a novel, microsphere-based, extended-release triamcinolone acetonide (TA) formulation, prolongs TA joint residence and reduces ...
P. Conaghan, D. Hunter, S. Cohen, V. Kraus, F. Berenbaum, J. Lieberman, Deryk G. Jones, A. Spitzer, D. Jevsevar, Nathaniel Katz, D. Burgess, J. Lufkin, James R. Johnson, N. Bodick   +13 more
semanticscholar   +4 more sources

The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems

Biomedicines, 2023
Ophthalmic drug delivery to the posterior segment of the eye has been challenging due to the complex ocular anatomy. Intravitreal injection of drugs was introduced to deliver therapeutic doses in the posterior segment.
Luis Abraham Aceves-Franco, Oscar Eduardo Sánchez‐Aguilar, Allen Rafael Barragan-Arias, M. A. Ponce-Gallegos, J. Navarro-Partida, Arturo Santos   +5 more
semanticscholar   +1 more source

Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE

Clinical and Experimental Ophthalmology, 2021
This post hoc analysis compared the efficacy and safety of suprachoroidally administered triamcinolone acetonide (CLS‐TA) to other commonly available treatments for non‐infectious uveitis.
M. Singer, P. Merrill, S. Yeh, Colette Hall, B. Kapik, T. Ciulla   +5 more
semanticscholar   +1 more source

Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery

Acta ophthalmologica, 2020
To compare the efficacy, safety and tolerability of a single perioperative subconjunctival injection of triamcinolone acetonide (TA) with steroid drops for the prevention of macular oedema and ocular inflammation after cataract surgery.
Juha-Matti Lindholm, Claudia Taipale, Petteri Ylinen, R. Tuuminen   +3 more
semanticscholar   +1 more source

Combination Therapy with 1% Nanocurcumin Gel and 0.1% Triamcinolone Acetonide Mouth Rinse for Oral Lichen Planus: A Randomized Double-Blind Placebo Controlled Clinical Trial

Dermatology research and practice, 2020
Objectives This study aimed to evaluate the efficacy of a combination of 1% nanocurcumin gel with 0.1% triamcinolone acetonide mouth rinse for oral lichen planus (OLP). Materials and Methods This double-blind randomized clinical trial was conducted on 31
M. Bakhshi, Shahzad Gholami, A. Mahboubi, M. Jaafari, M. Namdari   +4 more
semanticscholar   +1 more source

Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Journal of Ophthalmic Inflammation and Infection, 2020
The current article is a short review of an Alimera Sciences-sponsored symposium held during The 15th International Ocular Inflammation Society Congress in Taiwan on the 14th November 2019 entitled, ‘Preventing relapse of non-infectious uveitis effecting
B. Bodaghi, Q. Nguyen, G. Jaffe, R. Khoramnia, C. Pavesio   +4 more
semanticscholar   +1 more source

Triamcinolone acetonide intralesional injection for the treatment of keloid scars: patient selection and perspectives

Clinical, Cosmetic and Investigational Dermatology, 2018
Keloids are pathological scars presenting as nodular lesions that extend beyond the area of injury. They do not spontaneously regress, often continuing to grow over time.
M. Morelli Coppola, R. Salzillo, F. Segreto, P. Persichetti   +3 more
semanticscholar   +1 more source

A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye

Drug Delivery, 2019
As a leading cause of vision impairment of the retina, macular edema (ME) has one of the highest clinical demands for treatment. Current treatment of ME relies heavily on invasive techniques resulting in complications and poor patient compliance.
Jin Li, Tongjie Cheng, Q. Tian, Ying Cheng, Lixia Zhao, Xingzhen Zhang, Y. Qu   +6 more
semanticscholar   +1 more source

Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema

Journal of Ophthalmic Inflammation and Infection, 2019
BackgroundA retrospective observational clinical study to evaluate the safety and effectiveness of the injectable 0.19-mg fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of non-infectious uveitic macular edema.ResultsData are ...
Lea Weber, S. Marx, G. Auffarth, A. Scheuerle, T. Tandogan, C. Mayer, R. Khoramnia   +6 more
semanticscholar   +1 more source